The effect of curcumin on reserpine-induced depression-like behaviour in rats

Ahn, 2011, Escitalopram for the treatment of major depressive disorder in youth, Expert Opin. Pharmacother., 12, 2235, 10.1517/14656566.2011.604632 Alexopous, 2019, Mechanisms and treatment of late-life depression, Transl. Psychiatry, 9, 188, 10.1038/s41398-019-0514-6 Beach, 2014, Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation, J. Clin. Psychiatry, 75, e441, 10.4088/JCP.13r08672 Belleau, 2019, The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology, Biol. Psychiatry., 85, 443, 10.1016/j.biopsych.2018.09.031 Bhatt, 2020, Role of oxidative stress in depression, Drug Discov. Today, 25, 1270, 10.1016/j.drudis.2020.05.001 Bolfa, 2013, Photoprotective effects of Romanian propolis on skin of mice exposed to UVB irradiation, Food Chem. Toxicol., 62, 329, 10.1016/j.fct.2013.08.078 Ceglia, 2004, Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors, Br. J. Pharmacol., 142, 469, 10.1038/sj.bjp.0705800 Ceremuga, 2017, Investigation of the anxiolytic and antidepressant effects of curcumin, a compound from turmeric (Curcuma longa), in the adult male Sprague-Dawley rat, Holist. Nurs. Pract., 31, 193, 10.1097/HNP.0000000000000208 Cimen, 2016, The effects of escitalopram treatment on oxidative /antioxidative parameters in patients with depression, Klinik Psikofarmakol. Bülteni, 272 Czéh, 2016, Animal models of major depression and their clinical implications, Prog. Neuropsychopharmacol. Biol. Psychiatry, 64, 293, 10.1016/j.pnpbp.2015.04.004 Damoiseaux, 2014, Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives, Clin. Pharmacokinet., 53, 509, 10.1007/s40262-014-0145-2 Deacon, 2017, Omega 3 polyunsaturated fatty acids and the treatment of depression, Crit. Rev. Food Sci. Nutr., 57, 212, 10.1080/10408398.2013.876959 Eren, 2007, Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain, Neurochem. Res., 32, 1188, 10.1007/s11064-007-9289-x Hao, 2019, Selecting an appropriate animal model of depression, Int. J. Mol. Sci., 20, 4827, 10.3390/ijms20194827 Hu, 1994, Measurement of protein thiol groups and glutathione in plasma, Meth. Enzymol., 233, 380, 10.1016/S0076-6879(94)33044-1 Ikram, 2017, Repeated treatment with reserpine as a progressive animal model of depression, Pak. J. Pharm. Sci., 30, 897 Jiang, 2013, Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action, Prog. Neuropsychopharmacol. Biol. Psychiatry, 47, 33, 10.1016/j.pnpbp.2013.07.009 Kaufmann, 2016, Curcumin in depressive disorders: an overview of potential mechanisms, preclinical and clinical findings, Eur. J. Pharmacol., 784, 192, 10.1016/j.ejphar.2016.05.026 Kendrick, 2021, Strategies to reduce use of antidepressants, Br. J. Clin. Pharmacol., 87, 23, 10.1111/bcp.14475 Köhler, 2017, Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies, Acta Psychiatr. Scand., 135, 373, 10.1111/acps.12698 Kulkarni, 2008, Antidepressant activity of curcumin: involvement of serotonin and dopamine system, Psychopharmacology (Berl), 201, 435, 10.1007/s00213-008-1300-y Malhi, 2018, Depression, Lancet, 392, 2299, 10.1016/S0140-6736(18)31948-2 Matias, 2021, A systematic review of the antidepressant effects of curcumin: beyond monoamines theory, Aust. N. Z. J. Psychiatry, 55, 451, 10.1177/0004867421998795 Ménard, 2016, Pathogenesis of depression: insights from human and rodent studies, Neuroscience, 321, 138, 10.1016/j.neuroscience.2015.05.053 O'Neil, 2003, Animal models of depression: are there any?, Hum. Psychopharmacol., 239, 10.1002/hup.496 Pytkaa, 2016, The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect, Pharmacol. Rep., 68, 443, 10.1016/j.pharep.2015.10.006 Ramaholimihaso, 2020, Curcumin in depression: potential mechanisms of action and current evidence — a narrative review, Front. Psychiatry, 11, 10.3389/fpsyt.2020.572533 Sanmukhani, 2014, Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial, Phytother. Res., 28, 579, 10.1002/ptr.5025 Shahzad, 2014, Interactions of atenolol with alprazolam/escitalopram on anxiety, depression and oxidative stress, Pharmacol. Biochem. Behav., 117, 79, 10.1016/j.pbb.2013.12.015 Son, 2019, A chronic immobilization stress protocol for inducing depression-like behavior in mice, J. Vis. Exp., 10.3791/59546-v Spiers, 2015, Activation of the hypothalamic-pituitary-adrenal stress axis induces cellular oxidative stress, Front. Neurosci., 8, 456, 10.3389/fnins.2014.00456 Tasman, 2015 Unis, 2014, Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats, Can. J. Physiol. Pharmacol., 92, 226, 10.1139/cjpp-2013-0168 Villas Boas, 2019, Molecular aspects of depression: a review from neurobiology to treatment, Eur. J. Pharmacol., 851, 99, 10.1016/j.ejphar.2019.02.024 Yu, 2019, BDNF mediates the protective effects of scopolamine in reserpine-induced depression-like behaviors via up-regulation of 5-HTT and TPH1, Psychiatry Res., 271, 328, 10.1016/j.psychres.2018.12.015